Dr. Chi Li Joins Curevo Vaccine as Chief Regulatory Officer
April 08, 2024 10:00 ET
|
Curevo Vaccine
SEATTLE, April 08, 2024 (GLOBE NEWSWIRE) -- Curevo Vaccine (Curevo), a privately-held clinical-stage biotechnology company dedicated to developing varicella zoster virus vaccines with improved...
Curevo Vaccine Announces Positive Topline Results from Phase 2 Trial of Amezosvatein, a Next-Generation Vaccine for Shingles, Head-to-Head vs. Shingrix
January 07, 2024 11:00 ET
|
Curevo Vaccine
-- Positive data from 876-patient head-to-head trial versus Shingrix® shows amezosvatein met the primary immunogenicity endpoint, eliciting a robust immune response non-inferior to Shingrix, including...
Curevo Vaccine to present at the 42nd Annual J.P. Morgan Healthcare Conference
December 21, 2023 08:00 ET
|
Curevo Vaccine
SEATTLE, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Curevo Vaccine (Curevo), a privately held clinical-stage biotechnology company dedicated to reducing the burden of infectious disease by developing safe...
Guy De La Rosa, MD, Joins Curevo Vaccine as Chief Medical Officer
April 11, 2023 07:30 ET
|
Curevo Vaccine
SEATTLE, April 11, 2023 (GLOBE NEWSWIRE) -- Curevo Vaccine (Curevo), a privately held clinical-stage biotechnology company dedicated to reducing the burden of infectious disease by developing safe...
Did CDC Suppress Data on Chickenpox Vaccine? Asks Article in Journal of American Physicians and Surgeons
March 29, 2022 10:09 ET
|
Association of American Physicians and Surgeons
TUCSON, Ariz., March 29, 2022 (GLOBE NEWSWIRE) -- The chickenpox (varicella) vaccine has markedly decreased the incidence of chickenpox. Although chickenpox is almost always a mild disease,...
Fiber Cement Siding Market Size Worth $6,229.51 Mn, Globally, by 2028 at 6.7% CAGR - Exclusive Report by The Insight Partners
February 10, 2022 13:37 ET
|
The Insight Partners
New York, Feb. 11, 2022 (GLOBE NEWSWIRE) -- The latest research study on “Fiber Cement Siding Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Material (Portland Cement, Silica,...
Pfizer und BioNTech schließen neue globale Kollaborationsvereinbarung zur Entwicklung des ersten mRNA-basierten Impfstoffs gegen Gürtelrose
January 05, 2022 06:45 ET
|
BioNTech SE
Die dritte Kollaborationsvereinbarung der Unternehmen für mRNA-basierte Impfstoffe soll die Entwicklung eines verbesserten Impfstoffs gegen Gürtelrose beschleunigen; eine schwächende, entstellende und...
Pfizer and BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine
January 05, 2022 06:45 ET
|
BioNTech SE
Third mRNA vaccine collaboration between the companies aims to accelerate development of an improved vaccine for shingles, a debilitating, disfiguring and painful disease that affects people all over...
TAMKO ANNOUNCES RICK “THE ROOFER”: A PROFESSIONAL RESOURCE FOR CONTRACTORS
July 25, 2018 11:36 ET
|
TAMKO Building Products, Inc.
Joplin, Missouri, July 25, 2018 (GLOBE NEWSWIRE) -- TAMKO Building Products, Inc. is excited to announce a new resource for roofing industry professionals: Rick the Roofer, also known as Field Sales...
Expert Dermatologists Present Latest Information at 2018 AAD Annual Meeting
February 16, 2018 10:00 ET
|
American Academy of Dermatology
SAN DIEGO, Feb. 16, 2018 (GLOBE NEWSWIRE) -- The 2018 American Academy of Dermatology Annual Meeting will take place from Feb. 16 to 20 at the San Diego Convention Center. The meeting will feature...